Roppei Yamada
Impact in
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
- Cell Biology top 10%
- Endoplasmic Reticulum Stress and Disease
Papers in
-
- Gastric Cancer Management and Outcomes 15
- Metastasis and carcinoma case studies 7
- Lung Cancer Treatments and Mutations 3
- Oncology 18
- Colorectal Cancer Treatments and Studies 7
- Co-authors
- Nouri Neamati (3 shared papers)Shili Xu (2 shared papers)Yasushi Rino (25 shared papers)Toshio Imada (25 shared papers)Alexey N. Butkevich (2 shared papers)Nicos A. Petasis (2 shared papers)Ebrahim Zandi (2 shared papers)Yu Zhou (1 shared paper)
- Journals
- Oncology Reports (3 papers)Cancer Biology & Therapy (2 papers)Surgery Today (2 papers)Japanese Journal of Clinical Oncology (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- JapanUnited StatesItaly
In The Last Decade
Roppei Yamada
43 papers receiving 838 citations
Peers
Comparison fields: 5 of 98
- Gastroenterology 99
- Cell Biology 145
- Oncology 206
- Pulmonary and Respiratory Medicine 236
- Cancer Research 100
Countries citing papers authored by Roppei Yamada
This map shows the geographic impact of Roppei Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roppei Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roppei Yamada more than expected).
Fields of papers citing papers by Roppei Yamada
This network shows the impact of papers produced by Roppei Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roppei Yamada. The network helps show where Roppei Yamada may publish in the future.
Co-authors
The 25 scholars most cited alongside Roppei Yamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 180 | |
| 2 | 2008 | 54 | |
| 3 | 2012 | 51 | |
| 4 | 2015 | 44 | |
| 5 | 2015 | 42 | |
| 6 | 2013 | 40 | |
| 7 | 2005 | 33 | |
| 8 | 2010 | 31 | |
| 9 | 2000 | 31 | |
| 10 | 2015 | 28 | |
| 11 | Phase II study of docetaxel plus cisplatin as a second-line combined therapy in patients with advanced gastric carcinoma. | 2005 | 28 |
| 12 | Clinicopathological features of skip metastasis in colorectal cancer. | 2007 | 26 |
| 13 | 2011 | 25 | |
| 14 | 2008 | 24 | |
| 15 | 2009 | 21 | |
| 16 | 2009 | 19 | |
| 17 | 2012 | 18 | |
| 18 | Lateral lymph node dissection for lower rectal cancer. | 2007 | 18 |
| 19 | 1998 | 15 | |
| 20 | 2009 | 12 |
About Roppei Yamada
Roppei Yamada is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Gastroenterology, having authored 48 papers that have together received 856 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (15 papers), Metastasis and carcinoma case studies (7 papers), Colorectal Cancer Treatments and Studies (7 papers), Gastrointestinal Tumor Research and Treatment (6 papers), Esophageal Cancer Research and Treatment (3 papers), Cancer therapeutics and mechanisms (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Gastroenterology (99 citations), Cell Biology (145 citations), Oncology (206 citations), Pulmonary and Respiratory Medicine (236 citations) and Cancer Research (100 citations). Roppei Yamada has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Nouri Neamati, Shili Xu, Yasushi Rino, Toshio Imada, Alexey N. Butkevich, Nicos A. Petasis, Ebrahim Zandi, Yu Zhou, Bikash Debnath and Roger Duncan. Their work appears in journals such as Oncology Reports, Cancer Biology & Therapy, Surgery Today, Japanese Journal of Clinical Oncology and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.